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Introduction
In the recent years, a lot of engineered nanomaterials are being 
fabricated, whose applications are being investigated.This has fetched 
the attention of government and scientific community regarding the 
safety of these nanomaterials [1]. Graphene, an allotrope of carbon, has 
come into the limelight after ground breaking research conducted by 
Novoselov et al. [2]. They were awarded the Nobel Prize in physics in 
2010. Graphene is made up of a single layer of Sp2bonded carbon atom, 
arranged in a honeycomb lattice network. It has numerous unique 
physical properties like excellent electronic conductivity [3,4], superior 
mechanical strength [5], thermal conductivity [6], optical properties 
[7,8] and many more. These intriguing properties of graphene makes 
it suitable for electronic and biomedical applications like electrodes, 
transmitters, biosensing and cellular imaging, tissue engineering, 
targeted drug/gene delivery, photothermal therapy and so on [9,10]. 
Of particular interest is the biomedical application aspect of 
graphene. Yang et al. [11] studied the high uptake of nanographene 
by tumor and its efficient destruction through photothermal therapy. 
Nanographene has strong NIR optical absorption ability which was 
utilized for eradication of tumor via NIR laser irradiation. It has a large 
surface area and ability to adsorb numerous small molecules via π-π 
interactions [12]. It has also been shown to preferentially adsorb to single 
stranded DNA and RNA [12]. These properties are being utilized for 
drug delivery and bio sensing, respectively. Graphene, having superior 
mechanical strength and thermal properties, is also being considered 
in tissue engineering arena as reinforcement for scaffolds to increase 
its overall physical property [13,14]. These biological applications of 
nanographene require it to be biocompatible with the biological system. 
Adverse reaction to any material in vivo can lead to harmful, even fatal 
consequences and the initial aim of utilizing the material for the benefit 
of mankind will have an ironic ending. Hence, for any biomedical 
application, especially in vivo, great care must be taken to ensure that 
the toxicity of the nanomaterials is well characterized and understood. 
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Abstract
The intriguing properties of graphene has paved way for many potential biomedical applications like drug delivery, 
tissue engineered scaffold, bio sensing and so on. Here, we report the interaction of Maura reduced graphene oxide 
(MRGO) with the peripheral blood mononuclear cells (PBMNCs), as there is a likelihood of graphene coming in contact 
with the blood through intentional or accidental exposure. MRGO was synthesized by reducing graphene oxide using 
Halomonas Maura and autoclaved subsequently to prevent microbial contamination. It was characterized by TEM, AFM 
and FITR. Initial cytotoxicity was conducted in L929 cells to get the dose response. Oxidative stress potential, effect on 
proliferative capacity, genotoxicity and induction of apoptosis in PBMNCs treated with MRGO were assessed. MRGO 
elicited a dose dependent ROS generation which promoted apoptosis in PBMNCs. Proliferation of these cells were 
also found to be hindered. However, MRGO did not induce genotoxicity and generation of reactive nitrogen species. 
In conclusion MRGO shows a dose dependent toxicity in cells, generating ROS, inducing apoptosis and affecting 
proliferation, which may be due to the loss of exopolysaccharide coating due to autoclaving. This study raises a serious 
concern regarding the in vivo biomedical application of MRGO, where IV and IP are the main routes of exposure. 
Further evaluation is required regarding the interaction of autoclaved MRGO with the blood cells.
There are relatively few studies available on the toxicity of graphene. 
Zhang et al. [15] showed the cytotoxic effect of nanographene platelets 
on the human osteosarcoma cell (MG63). It was seen that, at a lower 
concentration, there was no obvious cytotoxicity. However, delayed cell 
cycle, induction of apoptosis and increased concentrations of TNF-α 
were noticed. Zhang et al. [16] compared the cytotoxicity level of 
carbon nanotubes (CNT) with graphene in PC-12 neural cells. They 
found that cytotoxicity and induction of oxidative stress was shape 
dependent, with CNT more toxic than nanographene. It was shown by 
Liao et al. [17] that aggregated graphene sheets showed less hemolytic 
activity of RBCs when compared to graphene oxide. 
With limited literature available on the toxicity and increasing 
concern regarding the safety of graphene, it has become pertinent 
to scrutinize more conclusively, the interaction of graphene with the 
biological system. For biomedical applications, the interaction of 
graphene with blood cells should be analyzed, as intraperitoneal (IP) 
and intravenous administrations (IV) are the major routes of exposure 
for these applications. Also any accidental exposure to graphene can 
also lead to its entry into the blood stream. In light of this, an effort 
was made here to investigate the toxicity of autoclaved MRGO with 
peripheral blood mononuclear cells (PBMNCs).
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Materials and Methods
Experimental animals
Swiss Albino mice were procured from the Division of Laboratory 
Animal Sciences of Biomedical technology wing, SCTIMST, 
Trivandrum, India. They were maintained in a 12 h light and dark cycle 
at controlled environmental conditions of temperature (22 ± 2ºC) and 
humidity (30-70%). Commercially available feed and filtered water were 
provided ad libitum. The experiments were performed after obtaining 
prior approval from the Institutional Animal Ethics Committee and 
as per the Committee for the Purpose of Control and Supervision of 
Experiments on Animals (CPCSEA) guidelines.
Synthesis and characterization of MRGO
Moderately halophilic bacterium, Halomonasmaura (ATCC 
700995) was purchased from ATCC and was propagated in MY medium 
as mentioned elsewhere [18,19].The medium was supplemented with 
various concentrations of graphene oxide (GO) for bacterial reduction. 
GO was synthesized via modified Hummer’s method using graphite 
powder (Ito Kokuen co., Ltd, Japan) [20]. So obtained GO was brownish 
in color and showed a uniform suspension. Sterilized MY medium was 
incorporated with different concentrations of GO. Subsequently, the 
culture bottles were flushed with ultrapure N2 and inoculated with H. 
maura. Bacterial reduction of GO takes place at 32oC in dark conditions 
and it was kept under incubation for 3-7 days. Rate of reduction 
depends upon the concentration of the GO added to the medium [21]. 
Black precipitate formed was the bacterially reduced GO, which was 
subjected to various purification steps and characterized using TEM 
and AFM. The MRGO was subsequently autoclaved to ensure there was 
no bacterial contamination. Comparison between autoclaved and non 
autoclaved MRGO was done using FTIR to characterize any change in 
MRGO due to the same. H. Maura reduced graphene oxide (MRGO) 
after characterization, was used for various biological and toxicological 
studies.
TEM images were taken using JEM- 2200FS, JEOL under a voltage 
of 200 Kv. AFM images were recorded using MFP-3D-CF, Asylum 
Research under non-contact AC-Air topographic mode with a scan 
rate of 1.0 Hz, using a V- shaped tapping tip. FTIR was also performed 
using Thermo Scientific, NICOLET iS50 ATR-FT-IR. Infrared spectra 
were recorded in the region of 4000-400 cm-1. Interactions of various 
functional groups and chemical bonds present in MRGO during the 
spontaneous bacterial reduction of GO can be found using ATR-FTIR. 
Similarly, the changes which took place during the autoclaving process 
of MRGO were also monitored using the same. Three samples were 
analyzed using ATR-FTIR- (1) Graphene Oxide (GO); (2) Autoclaved- 
MRGO; (3) Non-Autoclaved- MRGO.
Preparing MRGO solution
To prepare stock solution, appropriate amount of MRGO was 
dissolved in dimethyl sulphoxide (DMSO). The final concentration of 
DMSO in culture was kept below 1% to avoid toxic effect of DMSO. 
Prior to use, the particles were autoclaved to remove any contaminating 
bacteria that could affect the culture.
Cytotoxicity
Cytotoxicity MRGO in L929 cells were done using MTT 
(3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)assay 
[22]. The MTT assay relies on the activity of mitochondrial succinate 
dehydrogenase, of the live cell, in reducing yellow MTT to purple 
formazan [23]. This assay provides a measure of cell viability after 
being exposed to a substance. Briefly, L929 cell were seeded in 96 well 
plates at a density of 20,000 cells per well. Varying concentration of 
MRGO (25, 50, 100, 200, 300, 400, 500 and 600 µg/ml) was added after 
24h of incubation. Following an incubation of 24h with MRGO, the 
supernatant was removed and MTT was added and kept for 4h. After 
discarding the supernatant, the formazan crystals were solubilised with 
DMSO for 15 mins and then read at 540 nm spectrophotometrically 
(ELx 808 ultra microplate reader, Bio- Tek instruments, USA). Triplicate 
of each sample was done and untreated cells served as negative control. 
A DMSO control was also kept. 
Isolation of Peripheral blood mononuclear cells (PBMNCs)
Pooled blood was collected from healthy human volunteers (with 
informed consent) and mixed with heparin. PBMNCs were isolated 
using histopaque (Sigma, USA) at 400g for 30 minutes. Buffy layer was 
collected and washed twice with PBS and resuspended in RPMI 1640 
(Hi Media, India) supplemented with 10% FBS.
ROS generation
ROS generation in MRGO treated PBMNCs were assayed using 
DCFH-DA (2’7’- dicholoroflorescien acetate), a non fluorescent, cell 
permeate dye. DCFH-DA is converted to fluorescent DCF by the 
free radicals generated in the cell during oxidative stress. This can be 
monitored by using fluorescent spectrophotometer. The isolated cells 
were treated with DCFH-DA according to the protocol of Benedetti et 
al. [24]. Concisely, cells were incubated with DCFH-DA (Invitrogen, 
USA) for 30 minutes. The supernatant was discarded and different 
concentrations of MRGO (100, 300 and 600 µg/ml) were added. As 
the initial ROS production is being assessed, cells were incubated 
with MRGO for 4h only. After the period, fluorescence was read 
with excitation wavelength at 450nm and emission wavelength at 535 
nm using Plate ChameleonTM V (Hidex, Finland). 100 µM Hydrogen 
peroxide (H2O2) served as positive control and untreated cells served 
as negative control. 
Nitrosative stress
Production of Nitric oxide (NO) by inducible nitric oxide synthase 
(iNOS) was analyzed. Auto-oxidation of NO, results in the production 
of Nitrite. This can be measured by a colourimetric assay (Griess 
reagent) [25]. PBMNCs were isolated and 50,000 cells per well were 
seeded in a 96 well plate and kept for 24 h. MRGO was added in varying 
concentration (100, 300 and 600 µg/ml) to the culture and incubated 
for 24 h. Cells were pelleted and supernatant from PBMNC culture was 
incubated with equal volume of Griess reagent at RT for 10 minutes. 
Absorbance was measured at 540 nm (ELx 808 iu ultra microplate 
reader, Bio-Tek instruments, USA). The concentration of nitrite in the 
sample was determined from sodium nitrite standard curve.
Annexin V/Propidium Iodide Live dead assay
To determine induction of apoptosis in PBMNCs, cells were 
incubated with varying concentrations of MRGO (100, 300 and 600 µg/
ml) for 24 h and then analyzed by FACS. For FACS analysis, apoptotic 
cells were detected by staining with Annexin V and propidium iodide 
using Alexa Flour 488 Annexin V/Dead cell apoptosis kit (Invitrogen, 
USA). In brief, PBMNCs were washed twice in PBS and resuspended 
in 50 µl of annexin binding buffer (ABB). Annexin V (5 µl) and 1 µl 
propidium iodide (100 µg/ml) was added and samples were incubated 
in dark for 15 minutes before FACS analysis.
Spleenocyte proliferation assay
Proliferation of MRGO treated spleenic lymphocytes (spleenocytes) 
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were assessed by estimating the incorporation of [3H] thymidine. 
Spleenocytes from the spleen of Swiss Albino mice were isolated using 
histopaque and cultured in RPMI 1640 supplemented with 10% FBS. 
Cells were seeded onto 96 well plates at a cell density of 2 x 105 cells per 
well and kept in 37°C at 5% CO2. MRGO (100, 300 and 600 µg/ml) was 
added on the 24th hour of culture. At the 48th h, 0.5 µCi of [3H] thymidine 
was added per well. Cells were harvested at 72h and radioactivity was 
measured in cpm using scintillation counter (Hidex, Finland). Data is 
reported as mean cpm of triplicate samples. 
Chromosomal aberration
Chromosomal aberration assay was followed as per Vijayalakshmi 
et al. [26]. Heparinized, pooled blood was collected from healthy human 
volunteers (with informed consent) by venipuncture. 500 µl of blood 
was cultured in 4.5 mL of PB-MaxTM karyotyping media (Gibco, USA). 
100 and 600 µg of MRGO was added to the culture on the 48th hour. 
Colchicine (1 µg/ml) (Sigma, USA) was added one and half hour before 
72 h. The cells were harvested by centrifugation. The pellet was treated 
for 15mins with warm 0.56% KCl solution and centrifuged for 5 mins 
at 2500 rpm. The supernatant was discarded and the pellet was further 
fixed with chilled Methanol: Acetic acid (3:1). The pellet was dropped 
onto clean glass slides and stained with Giemsa. 50 metaphases were 
scored using an automated microscope with Metafer software (Carl 
Ziess, Germany). Mitomycin C (1 µg/ml) served as positive control 
whereas untreated cells were taken as control. 
Statistical analysis
All experiments were repeated thrice and all data are presented 
as the mean with the standard deviation (mean ± SD) except for 
chromosomal aberration assay. For chromosomal aberration assay 
Figure 1: Characterization of MRGO. a) TEM image of MRGO; b) AFM image of MRGO; c) Height retrace graph showing the cross sectional thickness 
of MRGO; d) FTIR spectra of GO, MRGO and autoclaved MRGO.
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mean with standard error (mean ± SE) was used to present data. 
Significance has been calculated using Student’s t-test. *denotes a 
statistical significance (p value *≤ 0.05 and **≤ 0.005) with respect to 
control. 
Results
Characterization of MRGO
TEM image of MRGO is shown in Figure 1a. It is clear from the 
image obtained that MRGO consist of various layers ranging from 
single to multilayer thicknesses. AFM image of the MRGO is shown 
in Figure 1b. The cross sectional view of the MRGO (Figure 1c) shows 
that the average thickness of the MRGO sheets is ~ 2.7 nm. FTIR 
spectra of GO (Figure 1d) show a comparatively stronger vibration at 
1030 cm-1 corresponding to the C- O bonding. Similarly, C=C and C=O 
vibrations were detected at 1612 cm-1 and 1722 cm-1 respectively. FTIR 
spectra of autoclaved and non- autoclaved MRGO reveal that there 
are no observable chemical changes occurring due to bond breaking 
with in the MRGO samples on autoclaving. It is evident from the figure 
that the FTIR spectra of MRGO both before and after the autoclaving 
process hold similar vibrations.
Cytotoxicity assay
Results from MTT assay shows a concentration dependent decrease 
in L929 cell viability (Figure 2). It was seen that up to 80% of cells were 
viable at a concentration of 50 µg/ml, which was statistically significant 
(p<0.05). However, there was a significant loss of cell viability, with only 
50% viability at a concentration of 500 µg/ml and 46% at 600 µg/ml 
(p<0.005). Hence it was found that the LC50 of autoclaved MRGO fell 
within the range of 500 µg/ml and 600 µg/ml. Viability of cells treated 
with DMSO (1%) was comparable with that of control and was not 
significant. 
ROS generation
To determine whether exposure to MRGO resulted in oxidative 
stress in PBMNCs, ROS generation was determined. Fluorescence 
emitted by the conversion of DCFH-DA to DCF due to internal ROS 
production is shown in Figure 3a. ROS generation was comparable 
with control in both DMSO control as well at 100 µg/ml MRGO treated 
PBMNCs. A significant increase in ROS was seen at 300 and 600 µg/
ml MRGO (300 µg/ml- 133429 ± 1357.25 and 600 µg/ml - 135692.5 
± 309.006) treated cells when compared to the control (129724.33 ± 
2289.517). 
Nitrosative stress
Increased concentration of NO can result in the formation of 
Reactive Nitrogen Species (RNS), which can be deleterious to the 
cell and can cause nitrosative stress. NO production by activation of 
inducible nitric oxide synthase (iNOS) in PBMNCs was indirectly 
measured by estimating the concentration of nitrite in the supernatant. 
From the results shown in Figure 3b, there is a slight raise in nitrite with 
increase in MRGO concentration but it was found to be statistically 
insignificant (Control - 5.958 ± 0.013 and 600 µg/ml of MRGO - 6.214 
± 0.004). From this, it is clear that ROS is the major contributor of 
oxidative stress. 
Annexin V/Propidium Iodide Live dead assay
To check whether the increase in ROS by MRGO causes apoptosis, 
presence of Annexin V was determined by FACS, as it is an apoptotic 
biomarker. The data from the live dead assay (Figure 4a-4e) indicated 
that only a small percentage of cells were undergoing apoptosis (early 
apoptosis) at higher concentrations. From Figure 4f we understand that 
there was a dose dependent increase (0.4-1.3% with respect to control) 
in the percentage of Apototic/ necrotic (Annexin V and PI- positive). 
Moreover, necrotic cell (PI-positive) were infrequent suggesting that 
MRGO induced death was mainly due to apoptosis. 
Spleenocyte proliferation assay
From the live/dead assay, it was clear that apoptosis occurred at 
Figure 2: Cytotoxicity of autoclaved MRGO using MTT assay in treated L929 
fibroblast cells. *p≤0.05; **p≤0.005
Figure 3: Oxidative stress potential of MRGO. a) ROS generation in PBMNCs 
treated with autoclaved MRGO. *p≤0.05; **p≤0.005; b) Concentration of 
Nitrite in supernantant of PBMNCs culture treated with autoclaved MRGO.
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Figure 4: Live/Dead assay using PBMNCs. a) control; b) DMSO 1%; c) d) e) 100µg/ml, 300µg/ml and 600µg/ml of autoclaved MRGO respectively; f) 
Percentage of autoclaved MRGO treated PBMNCs undergoing apoptosis/necrosis.
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a lower rate. In order to check whether the decrease in viability was 
the consequence of slower proliferation rate, spleenic lymphocyte 
proliferation was analyzed. Proliferation of spleenic lymphocytes was 
found to be affected, in a dose dependent manner, in cells exposed to 
MRGO. From Figure 5, it is evident that there was a significant decrease 
in proliferation of the spleenocytes. At 100 µg/ml, there was a marked 
decrease in incorporation of [3H] thymidine (15987.33 ± 1611.75) 
when compared to control (22283 ± 2396.20), indicating the decrease 
in proliferation of the treated cells. It was also seen that the proliferation 
rate of the spleenocytes was reduced by half at 600 µg/ml (11581 ± 
2341.37). Proliferation rate of DMSO treated cells were comparable 
with that of the control. 
Chromosomal aberration
As autoclaved MRGO resulted in a decreased proliferation of 
spleenic lymphocytes, analysis of aberration of chromosome was done, 
as DNA damage can result in cell cycle arrest at the check points. 
Results of chromosomal aberration are shown in Table 1 and Figure 
6a-e. Chromatid breaks (0.246 ± 0.077) and chromosome gap (0.014 
± 0.246) were seen at higher concentration of MRGO (600 µg/ml) but 
were not statistically significant when compared to control. Chromatid 
gaps were also seen at both lower (100 µg/ml -0.014 ± 0.015) and 
higher concentration (600 µg/ml- 0.087 ± 0.066) but again were not 
significant in comparison to control. However, it was interesting to note 
that, MRGO has a significant role in reduction of proliferation of the 
PBMNCs as evident from the Figure 7 showing mitotic index (Control 
-4.033 ± 0.088 and 600 µg/ml MRGO- 1.333 ± 0.241). Mitotic index 
represents the percentage of cells in metaphase per 1000 cells. Even 
though DMSO control treated cells showed chromatid breaks and gaps, 
they remained insignificant when compared to control as opposed to 
the mitomycin C treated cells.
Discussion
Graphene nanomaterials are gaining increasing prominence over 
the recent years for their unique physico-chemical properties. Numerous 
studies have been undertaken for tapping into these properties for 
nano-electronics as well as biomedical applications like bio-imaging, 
bio-sensing, drug delivery etc. As the common route of exposure of the 
particle for such applications involve IP or IV administration, the blood 
cells becomes susceptible to any potent damage that can be caused by 
the particle. So it is required to fully understand the interaction of a 
particle with the different cellular components of blood before in vivo 
applications. This study mainly focuses on the interaction of MRGO 
with the peripheral blood mononuclear cells.  
In this study, microbial reduction of GO by Halmonasmaura was 
employed as the method of MRGO synthesis. The conventional method 
of graphene synthesis involves employing high temperature, release of 
toxic and unstable gases [18], using highly toxic chemical agents like 
hydrazine hydrate for reduction. Industrial and biomedical applications 
demand the need for safer and non-toxic alternative routes for 
synthesis of graphene. Hence this environmental friendly approach was 
chosen for synthesis of graphene. As microorganisms were involved 
in synthesis, the particle was autoclaved prior use to ensure that the 
culture remained contamination free. For biomedical purposes, it is 
important to ensure that no microbial contamination will be there 
as it could cause adverse immunological responses to the material. 
Complete characterization of MRGO particle has been previously done 
by our group [18] and concurrent results were obtained in this study as 
well. Moreover the autoclaved and non autoclaved MRGO show similar 
vibration in the FTIR spectra which indicated that MRGO remained 
unchanged during autoclaving. 
From the cytotoxicity assay, a clear concentration dependent 
Figure 5: [3H] thymidine assay showing proliferation of MRGO treated spleenocytes.
Concentration Chromosome break (%) Chromosome gap (%) Chromatid break (%) Chromatid Gap (%) Other aberration (%)
Control 0 0 0 0.029 ± 0.029 0
DMSO 1% 0 0 0.087 ± 0.043 0.022 ± 0.031 0
Positive control 0 0 1.333 ± 0.038* 0.696 ± 0.066* 0.014 ± 0.015
MRGO (100µg/ml) 0 0 0 0.014 ± 0.015 0
MRGO (600µg/ml) 0 0.014 ± 0.246 0.246 ± 0.077 0.087 ± 0.066 0
Table 1: Percentage of chromosomal aberration in MRGO treated PBMNCs. * indicates a p value ≤0.05 which was considered significant.
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decline in cell viability was observed in L929 cell treated with autoclaved 
MRGO. This implies that the particle impairs the metabolic activity of 
the cells. From the previous study by Raveendran et al. [18], it is seen 
that the non autoclaved MRGO showed an increased proliferation rate 
for L929 cells, due to presence of bacterial exopolysaccharide (mauran) 
coating. Though, mauran is a stable polysaccharide, autoclaving the 
MRGO would have altered the biological properties of the same. Hence 
this could explain the contradictory results obtained in the study 
leading to decreased viability. L929 cells were used here to compare with 
the previous study and also to identify the dose response to autoclaved 
MRGO. From this assay, doses of 100, 300 and 600 µg/ml were selected 
throughout the study so as to understand whether the same outcome 
can be seen in the PBMNCs as well. Not only is that, doses at this level 
are normally administered for various in vivo applications.
Oxidative and nitrosative stress are one of the major mechanisms of 
toxicity of nanoparticles [27-30]. Oxidative stress occurs due to excess 
production of ROS and insufficient antioxidant defence mechanism. 
Whereas excess NO, produced by inducible nitric oxide synthase 
(iNOS), results in RNS formation. Both ROS and RNS reacts with various 
biological molecules resulting in detrimental effects to the cell causing 
lipid peroxidation, DNA base modification, protein modification and 
regulation of enzyme activity [31,32]. ROS production was evident in 
the present study following 4h incubation. This agrees with the previous 
reports, where graphene induced ROS generation in PC-12 cells [16]. 
Reports by Chang et al. [33] and Horvath et al. [34] also proved that 
graphene oxide induces ROS production in A549 cell and cells of the 
luminal surface of lungs respectively. Despite ROS generation, MRGO 
failed to stimulate the macrophages significantly, resulting in an 
insignificant NO formation. Hence it was found that PBMNCs treated 
with autoclaved MRGO followed ROS dependent toxicity pathway. 
ROS can trigger apoptotic events in the cell by causing mitochondrial 
membrane depolarization which leads to the release of cytochrome c, a 
central event for programmed cell death or apoptosis [35,36]. Various 
studies prove that carbon nanoparticles can induce apoptosis [37,38]. 
Earlier study on pristine graphene has also shown that it can induce 
apoptosis through the the MAPK and TGF-beta signaling pathway 
in the macrophage cells RAW 264.7 [39]. From the current study, 
autoclaved MRGO treated cells showed an increase in early apoptotic 
(Annexin V positive) and late apoptotic/necrotic (double positive) cells 
which followed a dose dependent trend. However, there was not any 
enormous increase in apoptosis. This led to believe that the decrease 
in activity of the cells might actually be the result of delayed cell cycle 
progression. To affirm that, spleenic lymphocyte proliferation capacity, 
post treatment with autoclaved MRGO, was assessed. It is known that 
carbon nanotubes induce cell cycle arrest at G1 phase [38]. Autoclaved 
MRGO was found to reduce the proliferation of spleenic lymphocyte 
in a concentration dependent manner in the present study. This is in 
correlation with the above MTT results in L929 cells, suggesting that 
autoclaved MRGO did, in fact, hinder proliferation of the cells. Cell 
cycle arrest normally occurs when there is DNA damage. Chromosome 
abnormalities are a consequence of DNA damage resulting from DNA 
strand breaks, mis-repair of damaged DNA and so on [40]. This can 
occur either by direct physical interaction of a genotoxic substance 
with DNA or indirectly by increasing free radicals which will attack 
the DNA [41]. Akhavan et al. [42] studied the genotoxic potential of 
reduced graphene oxide nanoplatelets in human mesenchymal stem 
cells (hMSCs) and found out that some genotoxicity was exhibited at 
low concentrations but were not remarkably significant, even at the 
highest dose (100 µg/ml). Even though, in this study, chromatid breaks 
were seen at higher dose (600 µg/ml), they were not significant. On 
the other hand, mitotic index was considerable reduced suggesting 
that autoclaved MRGO inhibits occurrence of mitosis by some other 
means. This indicates that decreased proliferation was not due to the 
DNA damage but some other reason. In a study by Matesanz et al. [43] 
 
Figure 6: Chromosomal aberration assay using PBMNCs (100X 
magnification) a) control, b) DMSO 1%, c)100 µg/ml autoclaved MRGO, d) 
600 µg/ml autoclaved MRGO where chromosome gap can be seen (1) and 
e) positive control Mitomycin C where chromatid break (2) and chromatid 
gap (3) are seen.
Figure 7: Mitotic index in MRGO treated PBMNCs. *p≤0.05; **p≤0.005.
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it was shown that graphene oxide nanosheets, when internalized by the 
cells, co-localized with the F-actin filaments. They observed delayed 
cell cycle, as actin microfilaments are required to be in one piece for 
cell cycle progression from G1, entry into S phase and mitotic division 
of the cells. This could also explain the results in the present study, 
which indicated decreased proliferation in spleenic lymphocytes and 
PBMNCs. 
Conclusion
MRGO was synthesized by Halomonasmaura mediated reduction 
of GO and characterized using TEM, AFM and FTIR. It was also found 
that the chemistry of MRGO upon autoclaving remained unchanged. 
However, changes might have occurred in the spontaneously coated 
mauranexo polysaccharide resulting in their toxic effects. Autoclaved 
MRGO showed dose dependent cytotoxicity in L929 cells. This 
was translated in the white blood cells as well, where a decreased 
proliferation, ROS generation and slight apoptosis even at 100 µg/ml 
were seen. This raises a serious concern regarding the compatibility of 
autoclaved MRGO with the biological system for biomedical purposes.
Hence a more stable biocompatible coating over MRGO must be 
considered for in vivo applications. Also more extensive studies are 
required to fully understand the proliferation pathway which is affected 
in cells, when treated with autoclaved MRGO. 
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